Enanta Pharmaceuticals Inc (ENTA)
EBITDA Growth
8.10%
Quarterly · Period ending:
ENTA EBITDA Growth
Year-over-year change vs the same period a year earlier
Latest reported8.10%period ending
Latest reported8.10%period ending
ENTA Quarterly EBITDA YoY % (-0.58% → 8.10%)
Year-over-year change
High-resolution chart · PNG
ENTA ebitda growth history
Quarterly. Dates are reporting period ends; fiscal years can differ from calendar years.
| Period ending | EBITDA Growth |
|---|---|
| 8.1049% | |
| 59.3049% | |
| 61.7175% | |
| 42.5974% | |
| 23.4083% | |
| 25.7764% | |
| 33.6973% | |
| -1.6695% | |
| 37.5575% | |
| 23.5691% | |
| -5.0405% | |
| -0.0701% | |
| -2.4339% | |
| -13.134% | |
| 2.9349% | |
| 21.2011% | |
| 3.5415% | |
| -13.5246% | |
| -157.0091% | |
| -72.6608% | |
| -48.5458% | |
| -163.3759% | |
| -182.9619% | |
| -357.7711% | |
| -572.7586% | |
| -2,083.2669% | |
| -51.7276% | |
| -79.1473% | |
| -80.0833% | |
| -102.8732% | |
| 90.6977% | |
| -35.9941% | |
| 285.235% | |
| 294.609% | |
| 348.6954% | |
| 2,637.4191% | |
| -1,820.1527% | |
| -6,701.5152% | |
| -116.7451% | |
| -155.7504% | |
| -135.0642% | |
| -100.271% | |
| -48.9145% | |
| 174.3482% | |
| -94.6603% | |
| 1,049.9122% | |
| 1,406.9305% | |
| -12.7053% | |
| 949.7207% | |
| -38.8678% | |
| -124.4603% | |
| -15.3252% | |
| -18.7825% | |
| -111.4826% | |
| 809.088% | |
| -0.5764% |